The FDA Has Extended The Target Action Date Of Its Review Of Organon's Supplemental New Drug Application For Vtama (Tapinarof) Cream, 1% For Atopic Dermatitis In Adults And Children Two Years Of Age And Older. The New Target Date Is March 12, 2025, Revise